ANEB earnings: a negative outcome, -10.3%

On May 11, 2022, Anebulo Pharmaceuticals, Inc. reached its earnings. The result was a negative outcome, and the stock moved -10.3% in the window around the event. It had already run -30.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.